Suven Life Science Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA-72-117
EBIT-77-121
Earning Per Share-5-9
Expenses94134
Net Profit-72-122
Net Profit Margin-535-1,030
Operating Profit Margin-537-988
Profit Before Tax-77-122
Dividends Per Share00
Operation Revenue2117

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
202298.23103.1086.202,445.2397.80
20221,739.202,486.90993.609,042.131,441.20
2022-1,229.80428.90-1,509.7011,900.64-1,372.50
20223,086.904,252.102,112.2018,985.902,991.10
20224,608.6011,319.203,405.8047,771.294,481.30
The EBITDA of Suven Life Science is -117 as of 3/23/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019202020212022
Operating Activities70-53-135-96-128
Investing Activities-13714656-22
Financing Activities-525335146
Others00000
Net Cash Flow17-1114-5-4

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2022-17.7518.85-5.82-4.72
20221,108.65-333.28-520.49254.88
2022367.311,292.23-1,572.3287.22
20163,262.60-2,039.40-1,700.10-476.90
20183,907.15-3,370.81-1,539.26-1,002.92
The cash flow from Operating Activities of Suven Life Science is -128 as of 3/23/2023